The gene-based RVAA also identified CHMP2B as having significantly fewer variants in the entire ONDRI cohort compared to controls, and NEFH as having significantly fewer variants in the CVD cohort compared to the controls or the combined AD/MCI cohort. Here, CHMP2B is linked to Alzheimer disease.